Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01124110 · ClinicalTrials.gov registry record · Phase 3
Tobacco Tactics Website for Operating Engineers
A Phase 3 study of Smoking and Tobacco Use Cessation, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 3
- Development phase
- 232
- Enrollment target
- 1
- Study location
NCT01124110: Completed Phase 3 study of Smoking and Tobacco Use Cessation, sponsored by University of Michigan.
NCT01124110 is a Phase 3 study of Smoking and Tobacco Use Cessation that has completed, run by University of Michigan. The registered enrollment target is 232 participants, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01124110, a Phase 3 study of Smoking and Tobacco Use Cessation, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 232 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clustered randomized control trial to test the Tobacco Tactics intervention among Operating Engineers (heavy equipment workers). The intervention group will be directed to the Tobacco Tactics website, and the control group will be directed to the state supported 1-800 quit-now telephone hotline during routine annual safety training that all Operating Engineers are required to attend. The web-based quitting intervention includes provision of over-the-counter nicotine replacement therapy and will be followed by nurse email and/or telephone counseling. It is expected that Operating Engineers who are randomized to the Tobacco Tactics website intervention will have at least equal or greater decreases in smoking at 30-day and 6-month follow-up compared to those randomized to the 1-800-QUIT-NOW quit line. In addition, the investigators expect to find that Operating Engineers randomized to the Tobacco Tactics website intervention will: a) be able to accomplish tasks; b) be able to accomplish goals with skill and speed; c) be able to operate the system; d) be satisfied with the website; e) access the site repeatedly; and f) spend time on the site during the intervention period.
Primary Outcome
The investigators will measure 7-day point prevalence abstinence by asking the well validated question, "Have you used any tobacco products (even one puff) in the past 7 days?" The investigators will also assess harm reduction (ability to quit at all, number of quit attempts, and number of cigarettes smoked per day).
Conditions Studied
Interventions
- BEHAVIORAL Tobacco Tactics Web-Based Intervention
- OTHER 1-800-QUIT-NOW Telephone Hotline
Study Locations (1)
Michigan
- University of Michigan, School of Nursing - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
What the finished NCT01124110 record still lists
NCT01124110 is an interventional study that assigns participants to a tested intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (49% lower).
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 2 interventions - of which Tobacco Tactics Web-Based Intervention is the first listed.
NCT01124110 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01124110 about?
NCT01124110 is a clinical study titled "Tobacco Tactics Website for Operating Engineers". This is a clustered randomized control trial to test the Tobacco Tactics intervention among Operating Engineers (heavy equipment workers). The intervention group will be directed to the Tobacco Tactics website, and the control group will be directed to the state supported 1-800 quit-now telephone ho...
What is the current status of trial NCT01124110?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 232 participants. The study started on 2010-01. Estimated completion is 2014-08.
What conditions does trial NCT01124110 study?
This clinical trial studies the following conditions: Smoking, Tobacco Use Cessation.
What interventions are being tested in trial NCT01124110?
The interventions under investigation include: Tobacco Tactics Web-Based Intervention (BEHAVIORAL), 1-800-QUIT-NOW Telephone Hotline (OTHER).
Who is sponsoring clinical trial NCT01124110?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01124110 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01124110's enrollment target sits among peer trials
232 52nd of 123 higher than 72 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integrating Financial Coaching and Smoking Cessation Coaching
RECRUITING · Phase 3
-
Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
-
Quitlink : A Leveraging Solution to Tobacco Counseling
COMPLETED · Phase 3
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia